period 30.3 10.2 198.4% Net Profit 11.2% 4.5% EBITDA (MB) 48.5 22.4 117.0% EBITDA (%) 18.0% 9.9% Earnings per share (Baht) 0.06 0.02 200.0% Remark : EBITDA = Profit before finance costs, income tax

Gross profit 98.77 56.14 48.74 56.88 50.03 102.63 Other income 0.08 0.04 3.77 4.40 (3.70) -98.01 Earnings before expenses 98.85 56.18 53.52 62.45 45.33 84.70 Administrative costs and management

Earnings before expenses 86.93 50.38 -7.35 -3.05 -11.10 -0.01 46.07 50.12 40.86 88.67 Administrative expenses Management benefit expenses Financial costs Income tax expense (12.68) (5.26) (19.15) (0.01

347.88 million, an increase of Baht 25.66 million or up by 7.96% as compared to the previous year. This was due to the higher earnings before tax. Table 2: Financial Summary for the nine-month period of

329.68 5.28 Selling and distribution expenses 68.89 63.23 8.95 66.19 4.09 216.39 195.29 10.81 Administrative expenses 42.17 46.09 -8.50 58.55 -27.98 130.69 134.40 -2.76 Earnings before interest and taxes

) (MB) % Share capital Registered 1,536.4 1,464.7 71.7 4.9 Share premium 808.2 736.5 71.7 9.7 Retained earnings – Unappropriated 1,824.6 1,692.0 132.6 7.8 Total shareholders' equity 4,324.0 4,053.3 270.7

71.7 9.7 Retained earnings – Unappropriated 1,702.1 1,692.0 10.1 0.6 Total shareholders' equity 4,202.7 4,053.3 149.4 3.7 -5- Share capital Registered increased by 71. 7 MB, representing an increase of 4

November 2019, PFR has the outstanding debts, i.e. the principal at 312,247,000 Baht and the accrued interest at 36,320,548 Baht which is the total amount of 348,567,548 Baht with the Purchaser, The Company

49.34 17.69% Finance cost 49.11 68.10 18.99 38.67% Income tax expenses 48.04 57.52 9.48 19.73% Net profit 181.71 202.58 20.87 11.49% Net profit ratio (ROS) 17.16% 15.74% Earnings per share (Baht) 0.34

outbreak control measures are being gradually relaxed and Vaccination is more progressive. 2). The effect of outstanding demand from the previous period and 3). Government measures that continue to bolster